Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cancer

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.22800PMID 17487835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

  2006cited by this paper
• Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.

  2006influential reference
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• MicroRNA-cancer connection: the beginning of a new tale.

  2006cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• c-Myc-regulated microRNAs modulate E2F1 expression

  2005cited by this paper
• A microRNA polycistron as a potential human oncogene

  2005cited by this paper
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

  2005cited by this paper
• MicroRNA profiling of the murine hematopoietic system

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• MicroRNA biogenesis: coordinated cropping and dicing

  2005cited by this paper
• Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

  2005cited by this paper
• Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.

  2005cited by this paper
• Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

  2005cited by this paper
• miRBase: microRNA sequences, targets and gene nomenclature

  2005cited by this paper
• The role of microRNA genes in papillary thyroid carcinoma.

  2005cited by this paper
• BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Extensive modulation of a set of microRNAs in primary glioblastoma.

  2005cited by this paper
• MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.

  2005cited by this paper
• Combinatorial microRNA target predictions

  2005cited by this paper
• CD117 expression in diffuse large B‐cell lymphomas: Fact or fiction?

  2005cited by this paper
• Rational Probe Optimization and Enhanced Detection Strategy for MicroRNAs Using Microarrays

  2005cited by this paper
• A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.

  2005cited by this paper
• Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

  2004cited by this paper
• Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

  2004cited by this paper
• Human MicroRNA Targets

  2004cited by this paper
• Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.

  2003cited by this paper
• Genesis: cluster analysis of microarray data

  2002cited by this paper
• Diffuse large cell lymphoma.

  2001cited by this paper
• Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells

  2001cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Diffuse large-cell lymphoma.

  2000cited by this paper

• Navigating the next frontier in biomedicine: breakthroughs and insights in nucleic acid therapeutics

  2026cites this paper
• Integration of imaging-based and sequencing-based spatial omics mapping on the same tissue section via DBiTplus.

  2026cites this paper
• miR-193-5p, miR-1307-5p, and miR-671-5p: Potential biomarkers for chemoresistance in diffuse large B-cell lymphoma

  2026cites this paper
• Anionic Liposomes as Optimal Membrane Fusion Carriers Enabling in Situ Multiplexed Detection of Extracellular Vesicle MicroRNAs

  2025cites this paper
• MicroRNA Expression in High‐Grade B‐Cell Lymphoma With 11q Aberration

  2025cites this paper
• miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy

  2025cites this paper
• Epigenetic Symphony in Diffuse Large B-Cell Lymphoma: Orchestrating the Tumor Microenvironment

  2025cites this paper
• MicroRNA155 in non-small cell lung cancer: a potential therapeutic target

  2025cites this paper
• miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas

  2025cites this paper
• Molecular mechanisms of viral oncogenesis in haematological malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling

  2025cites this paper
• The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic Leukemia.

  2025cites this paper
• MicroRNA dysregulation in male infertility: Insights into mechanisms, biomarkers, and therapeutic strategies- review

  2025cites this paper
• miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response

  2025cites this paper
• MicroRNA as a Potential Diagnostic and Prognostic Biomarker in Diffuse Large B‐Cell Lymphoma: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Challenges of using microRNAs as potential disease biomarkers. A review

  2024cites this paper
• The Multifaceted Role of miR-21 in Pancreatic Cancers

  2024cites this paper
• Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle‐Aged and Older Adults

  2024cites this paper
• The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma

  2024cites this paper
• Descriptive and Functional Genomics in Neonatal Respiratory Distress Syndrome: From Lung Development to Targeted Therapies

  2024cites this paper
• Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas

  2023cites this paper
• Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies

  2023cites this paper
• MicroRNA in lung cancer—a novel potential way for early diagnosis and therapy

  2023cites this paper
• Role of microRNAs in Chronic Lymphocytic Leukemia

  2023cites this paper
• miRNome expression analysis in canine diffuse large B-cell lymphoma

  2023cites this paper
• Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma

  2023cites this paper
• Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas

  2022cites this paper
• Knowledge and expectations about miRNAs as biomarkers in head and neck squamous cell cancers.

  2022cites this paper
• Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics

  2022cites this paper
• Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma

  2022cites this paper
• MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development.

  2022cites this paper
• Serum miR-21 predicts the prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma.

  2022cites this paper
• ALKBH5-mediated N6-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation

  2022cites this paper
• A microRNA signature for clinical outcomes of pediatric ALL patients treated with TPOG protocols.

  2022cites this paper
• Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway

  2022cites this paper
• MiR-1290: a potential therapeutic target for regenerative medicine or diagnosis and treatment of non-malignant diseases

  2022cites this paper
• MicroRNA and Their Potential Role in Conjunctival Disorders

  2022cites this paper
• Participation of different miRNAs in the regulation of YY1: Their role in pathogenesis, chemoresistance, and therapeutic implication in hematologic malignancies

  2021cites this paper
• Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology

  2021cites this paper
• Potential functions of hsa-miR-155-5p and core genes in chronic myeloid leukemia and emerging role in human cancer: A joint bioinformatics analysis.

  2021cites this paper
• Systematic Review of the Potential of MicroRNAs in the Management of Patients with Follicular Lymphoma.

  2021cites this paper
• Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients

  2021cites this paper
• Biology of splenic and nodal marginal zone lymphomas

  2021cites this paper
• Distinct microRNA expression signatures of primary and secondary central nervous system lymphomas.

  2021cites this paper
• One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies

  2021influential citation
• Advances in Lymphoma Molecular Diagnostics

  2021cites this paper
• Roles of Microvesicles in Tumor Progression and Clinical Applications

  2021cites this paper
• Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer

  2021cites this paper
• MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers

  2021cites this paper
• Computational and Bioinformatics Methods for MicroRNA Gene Prediction.

  2021cites this paper
• The Importance of miRNAs in The Immune System

  2020cites this paper
• miRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma.

  2020cites this paper
• A comparison of exosome purification methods using serum of Marek's disease virus (MDV)-vaccinated and -tumor-bearing chickens

  2020cites this paper
• Non-Coding RNAs in Diffuse Large B-Cell Lymphoma

  2020cites this paper
• LABEL FREE MICRO-RNA BIOMARKER DETECTION IN SERUM SAMPLES FOR POTENTIAL DIAGNOSIS APPLICATION AT POINT-OF-CARE SETTINGS

  2020influential citation
• Targeting microRNA in hematologic malignancies.

  2020cites this paper
• MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.

  2020cites this paper
• The Role of Noncoding RNAs in B-Cell Lymphoma

  2020cites this paper
• High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis

  2020cites this paper
• MiRNAs in outer membrane vesicles of gut microbiota: Friend or foe?

  2020cites this paper
• MicroRNA Biomarkers in Canine Diffuse Large B-Cell Lymphoma

  2020influential citation
• Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B‐cell lymphoma

  2020cites this paper
• MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

  2020cites this paper
• Diagnosis and treatment of lymphomas in the era of epigenetics.

  2020cites this paper
• Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo

  2020cites this paper
• Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma

  2020cites this paper
• Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.

  2019cites this paper
• Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP

  2019cites this paper
• Effect of rituximab combined with chemotherapy on the expression of serum exosome miR-451a in patients with diffuse large b-cell lymphoma.

  2019cites this paper
• Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma

  2019influential citation
• miR‐155 expression in antitumor immunity: The higher the better?

  2019cites this paper
• Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance.

  2019cites this paper
• Integrating random walk and binary regression to identify novel miRNA-disease association

  2019cites this paper
• Aberrant ERG expression associates with downregulation of miR‐4638‐5p and selected genomic alterations in a subset of diffuse large B‐cell lymphoma

  2019cites this paper
• Overexpression of microRNA-21 decreased the sensitivity of advanced cervical cancer to chemoradiotherapy through SMAD7

  2019cites this paper
• Identifying the optimal target genes associated with multiple myeloma by a novel bioinformatical analysis

  2019cites this paper
• Inflammation related miRNAs as an important player between obesity and cancers

  2019cites this paper
• Co-delivery Nanosystems for cancer treatment: A review.

  2019cites this paper
• The expression level of hsa-miR-146a-5p in plasma-derived exosomes of patients with diffuse large B-cell lymphoma

  2019cites this paper
• The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients

  2019cites this paper
• Plasma MicroRNA as a novel diagnostic.

  2019cites this paper
• MicroRNAs in diagnosis and therapeutics

  2019cites this paper
• Hematologic Malignancy Biomarkers in Proximal Fluids

  2019cites this paper
• Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia

  2019cites this paper
• Validation of extracellular miRNA quantification in blood samples using RT‐qPCR

  2019cites this paper
• Significance of the microRNA‑17‑92 gene cluster expressed in B‑cell non‑Hodgkin's lymphoma.

  2019cites this paper
• Reproducibility of quantitative real-time PCR analysis in microRNA expression profiling and comparisons with microarray assays in diffuse large B-cell lymphoma patients

  2019cites this paper
• Role of microRNA in Normal and Malignant Hematopoiesis

  2019cites this paper
• MicroRNA profiles in B-cell non-Hodgkin lymphoma

  2019influential citation
• Multiplexed fluorometric determination for three microRNAs in acute myocardial infarction by using duplex-specific nuclease and MoS2 nanosheets

  2019cites this paper
• Non-coding RNAs in Natural Killer/T-Cell Lymphoma

  2019cites this paper
• Clinical and Prognostic Value of Molecular Markers of Diffuse Large B-Cell Lymphoma

  2018influential citation
• Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma

  2018influential citation
• Maximal entropy random walk on heterogenous network for MIRNA-disease Association prediction.

  2018cites this paper
• miR-155 in cancer drug resistance and as target for miRNA-based therapeutics

  2018cites this paper
• Differential loading of the Argonaute complex in Epstein-Barr Virus (EBV)-infected cell lines derived from diffuse large B-cell lymphoma (DLBCL)

  2018cites this paper
• Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma

  2018cites this paper
• Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

  2018cites this paper
• Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study

  2018cites this paper
• MICRORNAS AS PREDICTORS OF ORAL CANCER

  2018cites this paper
• miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.

  2018cites this paper